HIGHLIGHTS
SUMMARY
Seasonal influenza vaccination (SIV) is the most effective means able to reduce this burden, and older adults are considered the primary target population for SIV (Cassini et_al, 2018; World Health Organization, 2012). For instance, the MF59 adjuvant induces a higher re- International Journal of Infectious Diseases 125 164-169 cruitment of key immune cells, promoting a more efficient antigen uptake and transport to local lymph nodes (O`Hagan et_al, 2012, 2013). This immune cascade typically results in both higher and wider immune_responses in aTIV recipients, as compared with non-adjuvanted standard-dose SIVs (Ansaldi . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.